Continuing Education Credit

The Robert H. Allen, MD, Memorial Hematology Symposia aims to share the latest developments in hematologic research, treatments, and clinical trials – both benign and malignant – with our local, state, and national community partners. Our goal is to help our clinical community partners:

• Identify which patients with hematologic malignancy may benefit from specific  targeted therapies
• Recognize myriad of causes of hematologic abnormalities, both non-malignant and malignant
• Identify higher-risk patients with hematologic malignancy and know the best available therapies for these patients
• Recognize best current approach to patients requiring more aggressive treatments
• Prescribe individualized plans for patients with hematologic diseases, both malignant and non-malignant, based on specific disease characteristics  (genetics, molecular markers, etc.)
• Manage both malignant and non-malignant hematologic diseases in the outpatient setting

Continuing education credit will be offered for most presentations.

The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This course is receiving up to 1 continuing nursing education contact hour through the UCHealth Department of Professional Development.

UCHealth is approved as a provider of nursing continuing professional development by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).